nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—HTR7—G alpha (s) signalling events—SCT—duodenum cancer	0.022	0.022	CbGpPWpGaD
Risperidone—DRD1—G alpha (s) signalling events—SCT—duodenum cancer	0.0189	0.0189	CbGpPWpGaD
Risperidone—KCNH2—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0156	0.0156	CbGpPWpGaD
Risperidone—HTR2B—G alpha (q) signalling events—GAST—duodenum cancer	0.0152	0.0152	CbGpPWpGaD
Risperidone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0136	0.0136	CbGpPWpGaD
Risperidone—HTR2C—G alpha (q) signalling events—GAST—duodenum cancer	0.0123	0.0123	CbGpPWpGaD
Risperidone—ADRA1B—G alpha (q) signalling events—GAST—duodenum cancer	0.0118	0.0118	CbGpPWpGaD
Risperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.011	0.011	CbGpPWpGaD
Risperidone—HTR2A—G alpha (q) signalling events—GAST—duodenum cancer	0.0107	0.0107	CbGpPWpGaD
Risperidone—HRH1—G alpha (q) signalling events—GAST—duodenum cancer	0.0107	0.0107	CbGpPWpGaD
Risperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0105	0.0105	CbGpPWpGaD
Risperidone—ADRA1A—G alpha (q) signalling events—GAST—duodenum cancer	0.0105	0.0105	CbGpPWpGaD
Risperidone—HTR1A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00979	0.00979	CbGpPWpGaD
Risperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00955	0.00955	CbGpPWpGaD
Risperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00953	0.00953	CbGpPWpGaD
Risperidone—HTR1D—G alpha (i) signalling events—SST—duodenum cancer	0.00946	0.00946	CbGpPWpGaD
Risperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.00935	0.00935	CbGpPWpGaD
Risperidone—HTR1B—G alpha (i) signalling events—SST—duodenum cancer	0.00926	0.00926	CbGpPWpGaD
Risperidone—DRD4—G alpha (i) signalling events—SST—duodenum cancer	0.00912	0.00912	CbGpPWpGaD
Risperidone—HTR2A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.00846	0.00846	CbGpPWpGaD
Risperidone—DRD3—G alpha (i) signalling events—SST—duodenum cancer	0.0081	0.0081	CbGpPWpGaD
Risperidone—HTR7—GPCR ligand binding—SCT—duodenum cancer	0.00797	0.00797	CbGpPWpGaD
Risperidone—HTR1D—GPCR ligand binding—SCT—duodenum cancer	0.00792	0.00792	CbGpPWpGaD
Risperidone—HTR1B—GPCR ligand binding—SCT—duodenum cancer	0.00776	0.00776	CbGpPWpGaD
Risperidone—DRD4—GPCR ligand binding—SCT—duodenum cancer	0.00763	0.00763	CbGpPWpGaD
Risperidone—HTR7—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00757	0.00757	CbGpPWpGaD
Risperidone—HTR1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00752	0.00752	CbGpPWpGaD
Risperidone—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00737	0.00737	CbGpPWpGaD
Risperidone—ADRA2B—G alpha (i) signalling events—SST—duodenum cancer	0.00731	0.00731	CbGpPWpGaD
Risperidone—HTR2B—GPCR ligand binding—SCT—duodenum cancer	0.00729	0.00729	CbGpPWpGaD
Risperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00725	0.00725	CbGpPWpGaD
Risperidone—HTR1A—G alpha (i) signalling events—SST—duodenum cancer	0.00706	0.00706	CbGpPWpGaD
Risperidone—HTR2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00692	0.00692	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.00687	0.00687	CbGpPWpGaD
Risperidone—ADRA2C—G alpha (i) signalling events—SST—duodenum cancer	0.00683	0.00683	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—SCT—duodenum cancer	0.00678	0.00678	CbGpPWpGaD
Risperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00652	0.00652	CbGpPWpGaD
Risperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00644	0.00644	CbGpPWpGaD
Risperidone—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.0062	0.0062	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—SCT—duodenum cancer	0.00612	0.00612	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—SCT—duodenum cancer	0.00591	0.00591	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.00588	0.00588	CbGpPWpGaD
Risperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00581	0.00581	CbGpPWpGaD
Risperidone—HTR7—GPCR ligand binding—SST—duodenum cancer	0.00577	0.00577	CbGpPWpGaD
Risperidone—HTR1D—GPCR ligand binding—SST—duodenum cancer	0.00573	0.00573	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—SCT—duodenum cancer	0.00572	0.00572	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00563	0.00563	CbGpPWpGaD
Risperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00561	0.00561	CbGpPWpGaD
Risperidone—HTR1B—GPCR ligand binding—SST—duodenum cancer	0.00561	0.00561	CbGpPWpGaD
Risperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00558	0.00558	CbGpPWpGaD
Risperidone—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00555	0.00555	CbGpPWpGaD
Risperidone—DRD4—GPCR ligand binding—SST—duodenum cancer	0.00552	0.00552	CbGpPWpGaD
Risperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00543	0.00543	CbGpPWpGaD
Risperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00534	0.00534	CbGpPWpGaD
Risperidone—HTR2B—GPCR ligand binding—SST—duodenum cancer	0.00527	0.00527	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.00519	0.00519	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00511	0.00511	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—SCT—duodenum cancer	0.00509	0.00509	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.005	0.005	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—SST—duodenum cancer	0.00497	0.00497	CbGpPWpGaD
Risperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00493	0.00493	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—SST—duodenum cancer	0.0049	0.0049	CbGpPWpGaD
Risperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00485	0.00485	CbGpPWpGaD
Risperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00484	0.00484	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—GAST—duodenum cancer	0.00475	0.00475	CbGpPWpGaD
Risperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00475	0.00475	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—GAST—duodenum cancer	0.00472	0.00472	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.00464	0.00464	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—GAST—duodenum cancer	0.00462	0.00462	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00455	0.00455	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—SCT—duodenum cancer	0.00451	0.00451	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—SCT—duodenum cancer	0.00448	0.00448	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—SST—duodenum cancer	0.00443	0.00443	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00441	0.00441	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—SCT—duodenum cancer	0.00438	0.00438	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—GAST—duodenum cancer	0.00434	0.00434	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—GAST—duodenum cancer	0.00432	0.00432	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.00431	0.00431	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—GAST—duodenum cancer	0.00429	0.00429	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—SST—duodenum cancer	0.00427	0.00427	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00425	0.00425	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—GAST—duodenum cancer	0.0042	0.0042	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—SST—duodenum cancer	0.00413	0.00413	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.00413	0.00413	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—SCT—duodenum cancer	0.00412	0.00412	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.0041	0.0041	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—SCT—duodenum cancer	0.00409	0.00409	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.00407	0.00407	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—SCT—duodenum cancer	0.00407	0.00407	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—GAST—duodenum cancer	0.00404	0.00404	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—SCT—duodenum cancer	0.00398	0.00398	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—GAST—duodenum cancer	0.00395	0.00395	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.00392	0.00392	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00388	0.00388	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—SCT—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—SST—duodenum cancer	0.00375	0.00375	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—SCT—duodenum cancer	0.00374	0.00374	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00372	0.00372	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00369	0.00369	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—SST—duodenum cancer	0.00368	0.00368	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—GAST—duodenum cancer	0.00367	0.00367	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—GAST—duodenum cancer	0.00365	0.00365	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00361	0.00361	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.00353	0.00353	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—GAST—duodenum cancer	0.00352	0.00352	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.0035	0.0035	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—SCT—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—SCT—duodenum cancer	0.00346	0.00346	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—GAST—duodenum cancer	0.00341	0.00341	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00336	0.00336	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00336	0.00336	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—SCT—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.00332	0.00332	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—GAST—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—SST—duodenum cancer	0.00326	0.00326	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—SST—duodenum cancer	0.00324	0.00324	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—SCT—duodenum cancer	0.00323	0.00323	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—GAST—duodenum cancer	0.0032	0.0032	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00318	0.00318	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.00318	0.00318	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—SST—duodenum cancer	0.00317	0.00317	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—SCT—duodenum cancer	0.00314	0.00314	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.00312	0.00312	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—GAST—duodenum cancer	0.0031	0.0031	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.00309	0.00309	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00305	0.00305	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00304	0.00304	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—GAST—duodenum cancer	0.00304	0.00304	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—SCT—duodenum cancer	0.00303	0.00303	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00302	0.00302	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00298	0.00298	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—SST—duodenum cancer	0.00298	0.00298	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—SST—duodenum cancer	0.00296	0.00296	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—SST—duodenum cancer	0.00294	0.00294	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—SCT—duodenum cancer	0.00293	0.00293	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00293	0.00293	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00289	0.00289	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00289	0.00289	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—SCT—duodenum cancer	0.00288	0.00288	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—SST—duodenum cancer	0.00288	0.00288	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00283	0.00283	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.00283	0.00283	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—SST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00276	0.00276	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—GAST—duodenum cancer	0.00276	0.00276	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.00271	0.00271	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—SST—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00262	0.00262	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00262	0.00262	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—SCT—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00257	0.00257	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—GAST—duodenum cancer	0.00255	0.00255	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00255	0.00255	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—GAST—duodenum cancer	0.00253	0.00253	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—SST—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00251	0.00251	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—SST—duodenum cancer	0.0025	0.0025	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—GAST—duodenum cancer	0.00248	0.00248	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—GAST—duodenum cancer	0.00244	0.00244	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SCT—duodenum cancer	0.00242	0.00242	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—SST—duodenum cancer	0.00241	0.00241	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SCT—duodenum cancer	0.0024	0.0024	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00238	0.00238	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SCT—duodenum cancer	0.00235	0.00235	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—SST—duodenum cancer	0.00234	0.00234	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—GAST—duodenum cancer	0.00233	0.00233	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00231	0.00231	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.0023	0.0023	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—SST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SCT—duodenum cancer	0.00221	0.00221	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—GAST—duodenum cancer	0.0022	0.0022	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—SST—duodenum cancer	0.00219	0.00219	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00218	0.00218	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—GAST—duodenum cancer	0.00217	0.00217	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—SST—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.00212	0.00212	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MEN1—duodenum cancer	0.00211	0.00211	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MEN1—duodenum cancer	0.0021	0.0021	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.00209	0.00209	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.00209	0.00209	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SCT—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—SST—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SCT—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MEN1—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00204	0.00204	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00202	0.00202	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—GAST—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MEN1—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.0019	0.0019	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—SST—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—GAST—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00188	0.00188	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SCT—duodenum cancer	0.00186	0.00186	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.00185	0.00185	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—GAST—duodenum cancer	0.00183	0.00183	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00182	0.00182	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.0018	0.0018	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MEN1—duodenum cancer	0.0018	0.0018	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SCT—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00178	0.00178	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SST—duodenum cancer	0.00175	0.00175	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SST—duodenum cancer	0.00174	0.00174	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SCT—duodenum cancer	0.00173	0.00173	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00172	0.00172	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00171	0.00171	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SST—duodenum cancer	0.0017	0.0017	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SST—duodenum cancer	0.00167	0.00167	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—GAST—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—GAST—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MEN1—duodenum cancer	0.00162	0.00162	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SST—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SCT—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MEN1—duodenum cancer	0.00157	0.00157	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00155	0.00155	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SCT—duodenum cancer	0.00154	0.00154	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00152	0.00152	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MEN1—duodenum cancer	0.00152	0.00152	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SST—duodenum cancer	0.00151	0.00151	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SST—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.00141	0.00141	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.00137	0.00137	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MEN1—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SST—duodenum cancer	0.00134	0.00134	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SST—duodenum cancer	0.0013	0.0013	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00129	0.00129	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SST—duodenum cancer	0.00125	0.00125	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SST—duodenum cancer	0.00114	0.00114	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SST—duodenum cancer	0.00112	0.00112	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SST—duodenum cancer	0.00112	0.00112	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.0011	0.0011	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.00102	0.00102	CbGpPWpGaD
